Philips Lumileds Selects Veeco's TurboDisc K465 GaN MOCVD Systems to Support LUXEON LED Production Ramp

Veeco Instruments Inc. (Nasdaq: VECO) announced today that Philips Lumileds Lighting Company, the world's leading manufacturer of high-power light emitting diodes (LEDs) and a solid-state lighting industry pioneer, has selected Veeco's TurboDisc K465 gallium nitride (GaN) Metal Organic Chemical Vapor Deposition (MOCVD) Systems to support its LUXEON LED production ramp. Veeco received a multi-system order for tools to be shipped to Philips Lumileds over the next two to three quarters.

Mike Pugh, Chief Procurement Officer at Philips Lumileds commented, “We have selected Veeco for several reasons. Veeco's K465 ultimately provides a high level of automation, helps us reduce manufacturing costs, and provides a flexible platform as we look to the future. Additionally, our confidence level in working with Veeco's systems and services is very high.”

John Peeler, Veeco's Chief Executive Officer, commented, “We are pleased to have been selected to help Philips Lumileds meet their solid-state lighting production ramp. The TurboDisc K465 has been designed to help customers seamlessly transition to larger wafer sizes, which we believe will be increasingly important to ensure a long capital life, lower customers' cost of ownership and increase their productivity.”

Veeco's TurboDisc K465 GaN MOCVD System is the only production-proven, fully automated MOCVD platform available on the market today. The "K-Series" MOCVD platform includes the K300 and K465 models, offering a modular, upgradeable path to a higher throughput, larger diameter reactor chamber and reduced cost of ownership.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.